Although direct evidence between IL-30 and the classical EMP markers remain elusive, IL-30 was shown to induce TNBC cell migration and the expression of a pro-oncogenic program to promote breast cancer growth and progression via STAT3 [158]. This evidence concerns the gene STAT3 and breast carcinoma.